Disposition and metabolism of 2,2′-dimorpholinodiethyl ether in sprague dawley rats and B6C3F1/N mice after oral, intravenous administration, and dermal application

References

• Black SR, Fennell TR, Mathews JM, et al. (2018). Disposition of [(14)C]hydroquinone in Harlan Sprague-Dawley rats and B6C3F1/N mice: species and route comparison. Xenobiotica 48:1128–41.
   PubMed Web of Science ®Google Scholar
• Brown RP, Delp MD, Lindstedt SL, et al. (1997). Physiological parameter values for physiologically based pharmacokinetic models. Toxicol Ind Health 13:407–84.
   PubMed Web of Science ®Google Scholar
• Case DE. (1975). Incorporation into endogenous metabolic pathways of small fragments derived from I.C.I, 58,834(vioxazine). Xenobiotica 5:133–43.
   PubMed Web of Science ®Google Scholar
• Cohen SA, Michaud DP. (1993). Synthesis of a fluorescent derivatizing reagent, 6-aminoquinolyl-N-hydroxysuccinimidyl carbamate, and its application for the analysis of hydrolysate amino acids via high-performance liquid chromatography. Anal Biochem 211:279–87.
   PubMed Web of Science ®Google Scholar
• Combourieu B, Besse P, Sancelme M, et al. (2000). Common degradative pathways of morpholine, thiomorpholine, and piperidine by Mycobacterium aurum MO1: evidence from (1)H-nuclear magnetic resonance and ionspray mass spectrometry performed directly on the incubation medium. Appl Environ Microbiol 66:3187–93.
   PubMed Web of Science ®Google Scholar
• Denissen JF, Grabowski BA, Johnson MK, et al. (1994). The orally active renin inhibitor A-74273. In vivo and in vitro morpholine ring metabolism in rats, dogs, and humans. Drug Metab Dispos 22:880–8.
   PubMed Web of Science ®Google Scholar
• ECHA. 2020. 2,2′-dimorpholinyldiethyl ether. Available from: https://echa.europa.eu/registration-dossier/-/registered-dossier/13298 [last accessed 16 Jun 2020].
   Google Scholar
• EPA. 2016. Chemical Data Reporting (CDR) database. U.S. Environmental Protection Agency. 2016. Available from: https://www.epa.gov/chemical-data-reporting/2016-chemical-data-reporting-results#access [last accessed 23 April 2019].
   Google Scholar
• Huntsman. 2004. JEFFCAT® Catalysts. Woodlands, TX: Huntsman LLC.
   Google Scholar
• Kitano M, Takada N, Chen T, et al. (1997). Carcinogenicity of methylurea or morpholine in combination with sodium nitrite in rat multi-organ carcinogenesis bioassay. Jpn J Cancer Res 88:797–806.
   PubMedGoogle Scholar
• Koissi N, Fishbein JC. (2013). Trapping of a cross-link formed by a major purine adduct of a metabolite of the carcinogen N-nitrosomorpholine by inorganic and biological reductants. Chem Res Toxicol 26:732–40.
   PubMed Web of Science ®Google Scholar
• Lenz EM, Martin S, Schmidt R, et al. (2014). Reactive metabolite trapping screens and potential pitfalls: bioactivation of a homomorpholine and formation of an unstable thiazolidine adduct. Chem Res Toxicol 27:968–80.
   PubMed Web of Science ®Google Scholar
• Lijinsky W, Reuber MD. (1982). Comparative carcinogenesis by nitrosomorpholines, nitrosooxazolidines and nitrosotetrahydrooxazine in rats. Carcinogenesis 3:911–5.
   PubMed Web of Science ®Google Scholar
• Lim HK, Chen J, Sensenhauser C, et al. (2011). Overcoming the genotoxicity of a pyrrolidine substituted arylindenopyrimidine as a potent dual adenosine A(2A)/A(1) antagonist by minimizing bioactivation to an iminium ion reactive intermediate. Chem Res Toxicol 24:1012–30.
   PubMed Web of Science ®Google Scholar
• Loeppky RN, Sukhtankar S, Gu F, Park M. (2005). The carcinogenic significance of reactive intermediates derived from 3-acetoxy- and 5-acetoxy-2-hydroxy-N-nitrosomorpholine. Chem Res Toxicol 18:1955–66.
   PubMed Web of Science ®Google Scholar
• Masic LP. (2011). Role of cyclic tertiary amine bioactivation to reactive iminium species: structure toxicity relationship. Curr Drug Metab 12:35–50.
   PubMed Web of Science ®Google Scholar
• Masson P, Alves AC, Ebbels TMD, et al. (2010). Optimization and evaluation of metabolite extraction protocols for untargeted metabolic profiling of liver samples by UPLC-MS. Anal Chem 82:7779–86.
   PubMed Web of Science ®Google Scholar
• Mohr U. (1979). Carcinogenesis of N-nitroso-morpholine and derivatives in Syrian golden hamsters. Prog Exp Tumor Res 24:235–44.
   PubMedGoogle Scholar
• NRC. 2011. Guide for the Care and Use of Laboratory Animals. 8th ed. Washington, DC: The National Academies Press.
   Google Scholar
• NTP. 2020a. Dimorpholinodiethyl ether CASRN 6425-39-4.
   Google Scholar
• NTP. 2020b. Testing Status of 2,2’-Dimorpholinodiethyl Ether.
   Google Scholar
• Nutley BP, Smith NF, Hayes A, et al. (2005). Preclinical pharmacokinetics and metabolism of a novel prototype DNA-PK inhibitor NU7026. Br J Cancer 93:1011–8.
   PubMed Web of Science ®Google Scholar
• Park BK, Laverty H, Srivastava A, et al. (2011). Drug bioactivation and protein adduct formation in the pathogenesis of drug-induced toxicity. Chem Biol Interact 192:30–6.
   PubMed Web of Science ®Google Scholar
• Slatter JG, Stalker DJ, Feenstra KL, et al. (2001). Pharmacokinetics, metabolism, and excretion of linezolid following an oral dose of [(14)C]linezolid to healthy human subjects. Drug Metab Dispos 29:1136–45., [(
   PubMed Web of Science ®Google Scholar
• Waidyanatha S, Black SR, Blystone CR, et al. (2020). Disposition and metabolism of sulfolane in Harlan Sprague Dawley rats and B6C3F1/N mice and in vitro in hepatocytes from rats, mice, and humans. Xenobiotica 50:442–12.
   PubMed Web of Science ®Google Scholar
• Waidyanatha S, Black SR, Snyder RW, et al. (2018a). Disposition and metabolism of the bisphenol analogue, bisphenol S, in Harlan Sprague Dawley rats and B6C3F1/N mice and in vitro in hepatocytes from rats, mice, and humans. Toxicol Appl Pharmacol 351:32–45.
   PubMed Web of Science ®Google Scholar
• Waidyanatha S, Ryan K, Sanders JM, et al. (2018b). Disposition of β-N-methylamino-l-alanine (L-BMAA), a neurotoxin, in rodents following a single or repeated oral exposure. Toxicol Appl Pharmacol 339:151–60.
   PubMed Web of Science ®Google Scholar
• Walters GI, Moore VC, Robertson AS, et al. (2013). Occupational asthma from sensitisation to 4,4-methylene-bismorpholine in clean metalworking fluid. Eur Respir J 42:1137–9.
   PubMed Web of Science ®Google Scholar
• Zhang M, Resuello CM, Guo J, et al. (2013). Contribution of artifacts to N-methylated piperazine cyanide adduct formation in vitro from N-alkyl piperazine analogs. Drug Metab Dispos 41:1023–34.
   PubMed Web of Science ®Google Scholar
• Zink CN, Soissons N, Fishbein JC. (2010). Products of the direct reaction of the diazonium ion of a metabolite of the carcinogen N-nitrosomorpholine with purines of nucleosides and DNA. Chem Res Toxicol 23:1223–33.
   PubMed Web of Science ®Google Scholar